Search Results - "Climent Durán, Miguel Á." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance

Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance

by Sridhar, Srikala S., Powles, Thomas, Climent Durán, Miguel Á., Park, Se Hoon, Massari, Francesco, Thiery-Vuillemin, Antoine, Valderrama, Begoña P., Ullén, Anders, Tsuchiya, Norihiko, Aragon-Ching, Jeanny B., Gupta, Shilpa, Petrylak, Daniel P., Bellmunt, Joaquim, Wang, Jing, Laliberte, Robert J., di Pietro, Alessandra, Costa, Nuno, Grivas, Petros, Sternberg, Cora N., Loriot, Yohann
Published in European urology (01.02.2024)

Get full text

Journal Article

Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study

Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study

by López-Abad, Alicia, Ramírez Backhaus, Miguel, Server Gómez, Gerardo, Cao Avellaneda, Enrique, Moreno Alarcón, Cristóbal, López Cubillana, Pedro, Yago Giménez, Pablo, de Pablos Rodríguez, Pedro, Juan Fita, María J., Climent Durán, Miguel Á., Guardiola Ruiz, Iris, Vidal Crespo, Natalia, Artés Artés, Miriam, Montoya Chinchilla, Raúl, Moreno Avilés, Juan, Guzmán Martínez-Valls, Pablo L., López González, Pedro Á.
Published in Prostate international (01.03.2024)

Get full text

Journal Article

Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma

Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma

by Grivas, Petros, Kopyltsov, Evgeny, Su, Po-Jung, Parnis, Francis X., Park, Se Hoon, Yamamoto, Yoshiaki, Fong, Peter C., Tournigand, Christophe, Climent Duran, Miguel A., Bamias, Aristotelis, Caserta, Claudia, Chang, Jane, Cislo, Paul, di Pietro, Alessandra, Wang, Jing, Powles, Thomas
Published in European urology (01.04.2023)

Get full text

Journal Article

Pembrolizumab (pembro) versus investigator’s choice of paclitaxel, docetaxel, or vinflunine in recurrent, advanced urothelial cancer (UC): 5-year follow-up from the phase 3 KEYNOTE-045 trial

Pembrolizumab (pembro) versus investigator’s choice of paclitaxel, docetaxel, or vinflunine in recurrent, advanced urothelial cancer (UC): 5-year follow-up from the phase 3 KEYNOTE-045 trial

by Bellmunt, Joaquim, Necchi, Andrea, De Wit, Ronald, Lee, Jae-Lyun, Fong, Lawrence, Vogelzang, Nicholas J., Climent Durán, Miguel A., Petrylak, Daniel P., Choueiri, Toni K., Gerritsen, Winald R., Gurney, Howard, Quinn, David I., Culine, Stephane, Sternberg, Cora N., Xu, Jin Zhi, Homet Moreno, Blanca, Godwin, James Luke, Bajorin, Dean F., Vaughn, David J., Fradet, Yves
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study

First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study

by Wheatley, Duncan A., Berardi, Rossana, Climent Duran, Miguel A., Tomiak, Anna, Greystoke, Alastair P., Joshua, Anthony M., Arkenau, Hendrik-Tobias, Géczi, Lajos, Corbacho, Javier Garciá, Paz-Ares, Luis G., Hussain, Syed A., Petruželka, Lubos, Delmonte, Angelo, Chappey, Colombe, Masters, Joanna C., Michelon, Elisabete, Murphy, Danielle A., Mwewa, Sandrine, Cesari, Rossano, Doger de Spéville, Bernard
Published in Cancer research communications (28.06.2024)

Get full text

Journal Article

PD55-01 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA IN THE JAVELIN BLADDER 100 TRIAL: SUBGROUP ANALYSIS BY DURATION OF TREATMENT-FREE INTERVAL FROM END OF CHEMOTHERAPY TO START OF MAINTENANCE

PD55-01 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA IN THE JAVELIN BLADDER 100 TRIAL: SUBGROUP ANALYSIS BY DURATION OF TREATMENT-FREE INTERVAL FROM END OF CHEMOTHERAPY TO START OF MAINTENANCE

by Sridhar, Srikala S., Powles, Thomas, Loriot, Yohann, Climent Durán, Miguel A., Gupta, Shilpa, Tsuchiya, Norihiko, Bamias, Aristotelis, Ardizzoni, Andrea, Ullén, Anders, Huang, Bo, Costa, Nuno, Laliberte, Robert J, di Pietro, Alessandra, Sternberg, Cora N, Grivas, Petros
Published in The Journal of urology (01.09.2021)

Get full text

Journal Article

Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC) in the JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval (TFI) from end of chemotherapy to start of maintenance

Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC) in the JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval (TFI) from end of chemotherapy to start of maintenance

by Sridhar, Srikala S., Powles, Thomas, Loriot, Yohann, Climent Durán, Miguel A., Gupta, Shilpa, Tsuchiya, Norihiko, Bamias, Aristotelis, Ardizzoni, Andrea, Ullén, Anders, Huang, Bo, Costa, Nuno Matos, Laliberte, Robert J, Di Pietro, Alessandra, Sternberg, Cora N., Grivas, Petros
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

PD38-02 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM OUTCOMES FROM JAVELIN BLADDER 100 IN SUBGROUPS DEFINED BY FIRST-LINE CHEMOTHERAPY REGIMEN AND ANALYSIS OF OVERALL SURVIVAL FROM START OF FIRST-LINE CHEMOTHERAPY

PD38-02 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM OUTCOMES FROM JAVELIN BLADDER 100 IN SUBGROUPS DEFINED BY FIRST-LINE CHEMOTHERAPY REGIMEN AND ANALYSIS OF OVERALL SURVIVAL FROM START OF FIRST-LINE CHEMOTHERAPY

by Sridhar, Srikala S., Powles, Thomas, Gupta, Shilpa, Climent Duran, Miguel A., Aragon-Ching, Jeanny B., Sternberg, Cora N., Cislo, Paul, Costa, Nuno, di Pietro, Alessandra, Bellmunt, Joaquim, Grivas, Petros
Published in The Journal of urology (01.05.2024)

Get full text

Journal Article

Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden

Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden

by Bellmunt, Joaquim, Powles, Thomas, Park, Se Hoon, Voog, Eric, Valderrama, Begoña Pérez, Gurney, Howard, Ullén, Anders, Loriot, Yohann, Sridhar, Srikala S., Tsuchiya, Norihiko, Sternberg, Cora N., Aragon-Ching, Jeanny B., Petrylak, Daniel P., Climent Duran, Miguel A., Tyroller, Karin, Hoffman, Jason, Jacob, Natalia, Grivas, Petros, Gupta, Shilpa
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: Results of the phase 2 KEYNOTE-B61 study

First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: Results of the phase 2 KEYNOTE-B61 study

by Lee, Chung-Han, Gurney, Howard, Atduev, Vagif, Suárez, Cristina, Climent Duran, Miguel A, Pook, David William, Tomczak, Piotr, Barthelemy, Philippe, Lee, Jae-Lyun, Nalbandian, Taron, Stus, Viktor, Ferguson, Thomas, Wiechno, Pawel, Gokmen, Erhan, Lacombe, Louis, Gedye, Craig, Burgents, Joseph, Sharma, Manish, Peng, Xiang, Albiges, Laurence
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study

First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study

by Wheatley, Duncan A, Berardi, Rossana, Climent Duran, Miguel A, Tomiak, Anna, Greystoke, Alastair P, Joshua, Anthony M, Arkenau, Hendrik-Tobias, Géczi, Lajos, Garcia-Corbacho, Javier, Paz-Ares, Luis G, Hussain, Syed A, Petruželka, Lubos, Delmonte, Angelo, Chappey, Colombe, Masters, Joanna C, Michelon, Elisabete, Murphy, Danielle A, Mwewa, Sandrine, Cesari, Rossano, Doger de Speville, Bernard
Published in Cancer research communications (26.04.2024)

Get full text

Journal Article

Phase I-II study to evaluate safety and efficacy of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial): Preliminary data of phase I study

Phase I-II study to evaluate safety and efficacy of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial): Preliminary data of phase I study

by Castellano, Daniel E., Duran, Ignacio, Mellado, Begona, Climent Duran, Miguel Angel A., Garcia del Muro, Xavier, Sala González, Nuria, Alonso Gordoa, Teresa, Sevillano, Elena, Domenech, Montserrat, Paramio, Jesus, Real, Francisco X., Malats, Nuria, Sanz, Juan Luis, Font, Albert
Published in Journal of clinical oncology (20.02.2022)

Get full text

Journal Article

A phase 2 study of the efficacy and safety of INCMGA00012 in advanced penile squamous cell carcinoma (PSqCC): ORPHEUS

A phase 2 study of the efficacy and safety of INCMGA00012 in advanced penile squamous cell carcinoma (PSqCC): ORPHEUS

by Garcia del Muro, Xavier, Riva, François, Cuellar, M. Andres, Maroto-Rey, Pablo, Castellano, Daniel E., Giannatempo, Patrizia, Climent Duran, Miguel Angel A., Necchi, Andrea, Pérez-Valderrama, Begoña, Gomez De Liano Lista, Alfonso, Garcias-Espana, Carmen, Puente, Javier, Ros, Silverio, Santander, Carmen, Masini, Cristina, Martínez de Falcon, Marta, Garcia, Almudena, Sampayo-Cordero, Miguel, Malfettone, Andrea, Paez, David
Published in Journal of clinical oncology (20.02.2022)

Get full text

Journal Article

Atezolizumab for locally advanced/metastatic urothelial carcinoma within the compassionate use program in Spain: The IMcompass study

Atezolizumab for locally advanced/metastatic urothelial carcinoma within the compassionate use program in Spain: The IMcompass study

by Climent Duran, Miguel Angel A., Perez-Gracia, Jose Luis, Arranz Arija, Jose Angel, Alvarez-Fernandez, Carlos, Gomez Mediavilla, Jenifer, Rodriguez, Angel, Vazquez-Estevez, Sergio, Jurado, Jose Miguel, Santander, Carmen, Bonfill, Teresa, Molins Palau, Carmen, Perez Ramirez, Sara, Pimentel Cáceres, Paola, Arnáiz, Pablo, Garate, Zita, Soto, Atenea, Puente, Javier
Published in Journal of clinical oncology (20.02.2022)

Get full text

Journal Article

Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial

Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial

by Roubaud, Guilhem, Kostine, Marie, McDermott, Raymond S., Bernard-Tessier, Alice, Maldonado, Xavier, Silva, Marlon, Flechon, Aude, Berthold, Dominik R., Ronchin, Philippe, Tombal, Bertrand F., Mourey, Loic, Gravis, Gwenaelle, Escande, Anne, Abadie Lacourtoisie, Sophie, Thiery-Vuillemin, Antoine, Climent Duran, Miguel Angel A., Ribault, Hélène, Bossi, Alberto, Foulon, Stéphanie, Fizazi, Karim
Published in Journal of clinical oncology (20.02.2022)

Get full text

Journal Article

A randomized phase 2 trial to evaluate the antitumor activity of enzalutamide (EZ) and talazoparib (TALA) for the treatment of metastatic hormone-naïve prostate cancer (mHNPC): ZZFIRST

A randomized phase 2 trial to evaluate the antitumor activity of enzalutamide (EZ) and talazoparib (TALA) for the treatment of metastatic hormone-naïve prostate cancer (mHNPC): ZZFIRST

by Mateo, Joaquin, Borque, Ángel, Castellano, Daniel E., Castro, Elena, Climent Duran, Miguel Angel A., Font, Albert, Lorente, David, Mellado, Begona, Rodriguez-Vida, Alejo, Cuadras, Merce, Planas, Jacques, Casanova Salas, Irene, Cordoba, Sarai, Gonzalez, Lucila, Martínez de Falcon, Marta, Fernández, Melissa, Sampayo-Cordero, Miguel, Malfettone, Andrea, Perez-Lopez, Raquel, Carles, Joan
Published in Journal of clinical oncology (20.02.2022)

Get full text

Journal Article

Neoadjuvant and adjuvant chemotherapy in bladder cancer

Neoadjuvant and adjuvant chemotherapy in bladder cancer

by Durán, Miguel A. Climent, Porta, Vicente Guillem
Published in Revista de oncología (Barcelona, Spain) (01.09.2000)

Get full text

Journal Article